Seer Inc - Class A (SEER) gains 3.26% for July 21

Equities Staff  |

Seer Inc - Class A (NASDAQ: SEER) shares gained 3.26%, or $1.07 per share, to close Wednesday at $33.88. After opening the day at $32.88, shares of Seer fluctuated between $34.61 and $32.64. 525,544 shares traded hands an increase from their 30 day average of 453,620. Wednesday's activity brought Seer’s market cap to $1,918,634,903.

About Seer Inc - Class A

Seek Inc. is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. The Company's Proteograph is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. The Company's designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

Visit Seer Inc - Class A’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Seer Inc - Class A and to follow the company’s latest updates, you can visit the company’s profile page here: Seer Inc - Class A’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content